May 21, 2021 · Objective: Our recent studies showed that desmocollin 1 (DSC1) binds to apoA-I in order to inhibit apoA-I-mediated high density lipoprotein ...
Explores the interactions between chemicals and living beings. The most cited pharmacology and pharmacy journal advances access to pharmacological discoveries ...
Missing: 2021.679456/ | Show results with:2021.679456/
The most cited pharmacology and pharmacy journal advances access to pharmacological discoveries to prevent and treat human disease.
Missing: 2021.679456/ | Show results with:2021.679456/
May 21, 2021 · Objective: Our recent studies showed that desmocollin 1 (DSC1) binds to apoA-I in order to inhibit apoA-I-mediated high density lipoprotein ...
... https://doi.org/10.3389/fphar.2022.928535. This article is part of the Research Topic Insights in Inflammation Pharmacology: 2021 View all 7 articles ...
Missing: 2021.679456/ | Show results with:2021.679456/
Apr 15, 2008 · Previous studies using washed platelets demonstrated that certain flavonoids inhibit platelet function through several mechanisms including ...
Dec 3, 2021 · These data suggest that pharmacological targeting of DSC1 may be more effective than increasing ABCA1 expression in promoting macrophage ...
May 6, 2010 · Full AccessResearch Article. PDF/EPUB ... Frontiers in Pharmacology, 10.3389/fphar.2021.679456, 12 ... https://doi.org/10.1161/ATVBAHA.110.207142.
Sep 22, 2021 · The results showed that esculetin and luteolin could dose-dependently inhibit H2O2-induced cell apoptosis at 5, 10, and 20 μmol/L, and esculetin ...
Missing: 2021.679456/ | Show results with:2021.679456/
Objective: Our recent studies showed that desmocollin 1 (DSC1) binds to apoA-I in order to inhibit apoA-I-mediated high density lipoprotein (HDL) biogenesis ...